BREAKING: Mota Ventures Signs Letter of Intent for Merger with Stillcanna

• Stillcanna looks to become one of the largest producers of THC-free CBD extracts in Europe
• Stillcanna's Polish extraction facility, NEXUS, features industrial-scale centrifugal chromatography equipment that allows for the production of bulk THC-free CBD distillate as well as custom Cannabinoid profiles
• In February 2020, Stillcanna's Romanian extraction facility, ORIGIN, which operates pursuant to a joint venture between Stillcanna and Dragonfly Biosciences Ltd., received approval from the Ministry of Health and the Anti-Drug Agency to become the first government recognized extraction facility in the country
• To date C$23,000,000 has been invested by Stillcanna in the cultivation and extraction operations,
• Current cash on hand in Stillcanna of approximately C$7,000,000
• Stillcanna's CBD extracts are key to unlocking additional value in Mota's retail offerings in Europe
• Shareholders of Stillcanna would receive one common share of Mota for every 1.8 common shares of Stillcanna held at the time of exchange

Hub On AGORACOM / Read Release